![Galya Blachman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Galya Blachman
General Counsel bei
501 ACQU
Profil
Galya D.
Blachman is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.
Aktive Positionen von Galya Blachman
| Unternehmen | Position | Beginn |
|---|---|---|
| 501 ACQU | General Counsel | 01.09.2020 |
| ENLIVEN THERAPEUTICS, INC. | General Counsel | 01.07.2023 |
Biotech Connection-Bay Area, Inc.
 Biotech Connection-Bay Area, Inc. Biotech Connection-Bay Area, Inc. is a non-profit organization that connects academic science trainees with the biotech industry. The private company is based in California. The organization provides hands-on consulting and due diligence projects to clients in the life sciences sector, focusing on market research, pipeline prioritization, competitive landscaping, business development, and new product strategy. Its projects span areas such as cancer screening, genomic medicine, neurodegenerative diseases, and drug discovery platforms. Biotech Connection-Bay Area also offers experiential learning opportunities to help trainees build business and consulting skills for non-academic careers in life sciences, publishes articles and market reports on biotech topics, promotes diversity, equity, and inclusion initiatives, and engages the community through events and communications. | General Counsel | 01.06.2018 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | General Counsel | 01.09.2018 |
Ehemalige bekannte Positionen von Galya Blachman
| Unternehmen | Position | Ende |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | General Counsel | 01.01.2017 |
AbbVie Stemcentrx LLC | Corporate Officer/Principal | - |
Ausbildung von Galya Blachman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
BPP Law School
 BPP Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Stemcentrx LLC | |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Biotech Connection-Bay Area, Inc.
Biotech Connection-Bay Area, Inc. Biotech Connection-Bay Area, Inc. is a non-profit organization that connects academic science trainees with the biotech industry. The private company is based in California. The organization provides hands-on consulting and due diligence projects to clients in the life sciences sector, focusing on market research, pipeline prioritization, competitive landscaping, business development, and new product strategy. Its projects span areas such as cancer screening, genomic medicine, neurodegenerative diseases, and drug discovery platforms. Biotech Connection-Bay Area also offers experiential learning opportunities to help trainees build business and consulting skills for non-academic careers in life sciences, publishes articles and market reports on biotech topics, promotes diversity, equity, and inclusion initiatives, and engages the community through events and communications. | |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
